Australia's most trusted
source of pharma news
Monday, 11 May 2026
Posted 11 May 2026 AM
![]() |
| Artist's impression of ION exterior terrace |
Sydney’s first dedicated, purpose-built commercial life sciences precinct named ION is scheduled to open its doors in the fourth quarter of 2028, with three inaugural partners announced.
Behind the new commercial precinct is Kurraba Group, an Australian life sciences real estate firm that partners with investors and landowners to invest in, develop and manage complex projects.

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.